Heart Disease News and Research

Latest Heart Disease News and Research

Hormonal shifts in menopause redefine women’s microbiome and risks

Research explores how menopause-induced hormonal shifts affect the microbiome, influencing oral, gut, and urogenital health, and highlights the potential of personalized interventions to enhance well-being.

15 Jan 2025

PIN1 protein found to be a significant driver of bladder cancer

Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could put a lid on their growth?

15 Jan 2025

Study identifies molecular mechanisms behind gestational diabetes progression

Among those who have had gestational diabetes, about 35% will develop type 2 diabetes within a decade.

15 Jan 2025

Racism in obstetric care linked to higher blood pressure in mothers

Mothers of color who faced racism or microaggressions during obstetric care had higher blood pressure after delivering their babies compared to people of color who did not report racism during their care, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

15 Jan 2025

Overcoming limitations of traditional CVD drugs

Announcing a new publication for Acta Materia Medica journal. Cardiovascular diseases (CVDs) pose a significant threat to human health due to the high mortality and morbidity rates. Traditional drugs often have limited efficacy due to inherent constraints, such as low bioavailability and notable side effects.

15 Jan 2025

The role of inflammation in the pathogenesis of heart failure

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Cardiovascular disease remains a leading cause of death and disability worldwide. Heart failure (HF) is the end stage of various cardiovascular diseases. Despite recent advancements in understanding of HF pathogenesis and treatment, the prognosis of patients with HF remains poor.

15 Jan 2025

New model analyzes CT scans to identify high-risk individuals

Researchers at Case Western Reserve University, University Hospitals and Houston Methodist will harness the power of artificial intelligence (AI) to more accurately predict risk of heart failure and other cardiovascular events, including estimating when an adverse event might occur, by developing an AI model that "learns" from patient scans.

15 Jan 2025

Morning coffee cuts health risks, but all-day sipping doesn’t

Moderate morning coffee consumption may lower all-cause and cardiovascular mortality risks, but coffee consumed throughout the day offers no similar benefits.

13 Jan 2025

New push for stricter chemical laws to shield kids from harmful exposure

Research highlights the rising impact of synthetic chemicals on children's health, linking them to noncommunicable diseases and advocating for stringent global regulations.

13 Jan 2025

U.S. dementia cases expected to surge with aging population

A new study shows that the risk of developing dementia anytime after age 55 among Americans is 42%, more than double the risk reported by older studies.

13 Jan 2025

Women experience higher waiting-list mortality in lung transplantation

Research highlights gender-based disparities in lung transplantation, showing women face longer wait times yet achieve better post-transplant survival outcomes.

13 Jan 2025

New test could predict lung cancer outcomes using tumor DNA

Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to detect circulating tumor DNA can predict lung cancer outcome in a Cancer Research UK-funded study.

13 Jan 2025

Can medical schools funnel more doctors into the primary care pipeline?

Throughout her childhood, Julia Lo Cascio dreamed of becoming a pediatrician. So, when applying to medical school, she was thrilled to discover a new, small school founded specifically to train primary care doctors: NYU Grossman Long Island School of Medicine.

13 Jan 2025

Gut bacterium associated with reduced dietary sugar intake

This study links Ffar4, gut microbiota, and sugar preference, highlighting potential strategies for managing diabetes and obesity through dietary interventions.

13 Jan 2025

Sleep loss triggers intrusive memories by disrupting REM sleep

Sleep deprivation affects the brain's memory control, with REM sleep essential for effective suppression of intrusive memories and cognitive function.

13 Jan 2025

Boston Scientific announces agreement to acquire Bolt Medical, Inc.

Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for the treatment of coronary and peripheral artery disease.

From Boston Scientific 13 Jan 2025

Mortality risks soar with ultra-processed foods - simple diet changes can help

Ultra-processed food consumption increases mortality risks, particularly from circulatory, digestive diseases, and Parkinson's, but substituting minimally processed foods can lower these risks.

12 Jan 2025

Being fit matters more than weight for long-term health, research shows

Cardiorespiratory fitness significantly reduces mortality risks regardless of BMI, highlighting fitness as a critical health determinant over weight loss strategies.

12 Jan 2025

New software tool offers insights into 3D imaging of heart development

Researchers have developed a new software tool that provides unprecedented capabilities to see inside 3D images.

10 Jan 2025

Menarini Group signs licensing deal with Insilico for promising cancer treatment

The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to cancer patients, and Insilico Medicine ("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, today announced that the companies have entered into an exclusive licensing agreement granting Stemline the global rights to develop and commercialize a preclinical small molecule targeting high unmet needs in oncology.

10 Jan 2025